Zobrazeno 1 - 10
of 95
pro vyhledávání: '"Bulur, Peggy"'
Publikováno v:
In Cytotherapy January 2025 27(1):121-127
Autor:
Lin, Yi *, Marin-Argany, Marta *, Dick, Christopher J., Redhage, Keely R., Blancas-Mejia, Luis M., Bulur, Peggy, Butler, Greg W., Deeds, Michael C., Madden, Benjamin J., Williams, Angela, Wall, Jonathan S., Dietz, Allan, Ramirez-Alvarado, Marina *
Publikováno v:
In Cytotherapy December 2017 19(12):1426-1437
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Lin, Yi, Gustafson, Michael P., Bulur, Peggy A., Gastineau, Dennis A., Witzig, Thomas E., Dietz, Allan B.
Publikováno v:
In Blood 20 January 2011 117(3):872-881
Autor:
Vuk-Pavlović, Stanimir, Bulur, Peggy A., Lin, Yi, Qin, Rui, Szumlanski, Carol L., Zhao, Xinghua, Dietz, Allan B.
Publikováno v:
ETSU Faculty Works.
OBJECTIVE. To determine if the levels of circulating myeloid-derived suppressor cells increase with progression of prostate cancer (PCa); to determine if such cells could contribute to the relative inefficiency of PCa immunotherapy. MATERIALS AND MET
Externí odkaz:
https://dc.etsu.edu/etsu-works/16790
Autor:
Fisher, Phyllis J., Bulur, Peggy A., Vuk-Pavlovic, Stanimir, Prendergast, Franklyn G., Dietz, Allan B.
Publikováno v:
In Blood 15 December 2008 112(13):5037-5045
Publikováno v:
Cancers; Sep2022, Vol. 14 Issue 18, pN.PAG-N.PAG, 13p
Autor:
Dietz, Allan B. *, Souan, Lina, Knutson, Gaylord J., Bulur, Peggy A., Litzow, Mark R., Vuk-Pavlović, Stanimir
Publikováno v:
In Blood 15 August 2004 104(4):1094-1099
Autor:
Fisher, Phyllis J. *, Springett, Margaret J., Dietz, Allan B., Bulur, Peggy A., Vuk-Pavlović, Stanimir
Publikováno v:
In Journal of Immunological Methods 2002 262(1):95-101
Autor:
Allred Jacob B, Bulur Peggy A, Padley Douglas J, Butler Greg W, Maas Mary L, Greiner Carl W, Dietz Allan B, Markovic Svetomir N, Creagan Edward T, Ingle James N, Gastineau Dennis A, Vuk-Pavlovic Stanimir
Publikováno v:
Journal of Translational Medicine, Vol 4, Iss 1, p 35 (2006)
Abstract Background Dendritic cells (DCs) have been used as vaccines in clinical trials of immunotherapy of cancer and other diseases. Nonetheless, progress towards the use of DCs in the clinic has been slow due in part to the absence of standard met
Externí odkaz:
https://doaj.org/article/7413a488a1474ea9917808d06bbe1930